1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Targeted biologic therapies 1.2.3 Novel therapies 1.3 Market by Application 1.3.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Pharmacy Store 1.3.4 Online Pharmacy Stroe 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Perspective (2016-2027) 2.2 Immune-Mediated Inflammatory Diseases Treatment Growth Trends by Regions 2.2.1 Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Immune-Mediated Inflammatory Diseases Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Immune-Mediated Inflammatory Diseases Treatment Industry Dynamic 2.3.1 Immune-Mediated Inflammatory Diseases Treatment Market Trends 2.3.2 Immune-Mediated Inflammatory Diseases Treatment Market Drivers 2.3.3 Immune-Mediated Inflammatory Diseases Treatment Market Challenges 2.3.4 Immune-Mediated Inflammatory Diseases Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue 3.1.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue (2016-2021) 3.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Immune-Mediated Inflammatory Diseases Treatment Revenue 3.4 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio 3.4.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2020 3.5 Immune-Mediated Inflammatory Diseases Treatment Key Players Head office and Area Served 3.6 Key Players Immune-Mediated Inflammatory Diseases Treatment Product Solution and Service 3.7 Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Type 4.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Type (2016-2021) 4.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2022-2027) 5 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Application 5.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Application (2016-2021) 5.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size (2016-2027) 6.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type 6.2.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) 6.2.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) 6.2.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2027) 6.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application 6.3.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) 6.3.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) 6.3.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2027) 6.4 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country 6.4.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) 6.4.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size (2016-2027) 7.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type 7.2.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) 7.2.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) 7.2.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2027) 7.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application 7.3.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) 7.3.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) 7.3.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2027) 7.4 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country 7.4.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) 7.4.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size (2016-2027) 8.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type 8.2.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application 8.3.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region 8.4.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size (2016-2027) 9.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type 9.2.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2027) 9.3 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application 9.3.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2027) 9.4 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country 9.4.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size (2016-2027) 10.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type 10.2.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application 10.3.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country 10.4.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Company Details 11.1.2 GlaxoSmithKline Business Overview 11.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Introduction 11.1.4 GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) 11.1.5 GlaxoSmithKline Recent Development 11.2 Eli Lilly 11.2.1 Eli Lilly Company Details 11.2.2 Eli Lilly Business Overview 11.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Introduction 11.2.4 Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) 11.2.5 Eli Lilly Recent Development 11.3 AstraZeneca 11.3.1 AstraZeneca Company Details 11.3.2 AstraZeneca Business Overview 11.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Introduction 11.3.4 AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) 11.3.5 AstraZeneca Recent Development 11.4 Bristol-Myers 11.4.1 Bristol-Myers Company Details 11.4.2 Bristol-Myers Business Overview 11.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Introduction 11.4.4 Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) 11.4.5 Bristol-Myers Recent Development 11.5 Sanofi 11.5.1 Sanofi Company Details 11.5.2 Sanofi Business Overview 11.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Introduction 11.5.4 Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) 11.5.5 Sanofi Recent Development 11.6 Roche 11.6.1 Roche Company Details 11.6.2 Roche Business Overview 11.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Introduction 11.6.4 Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) 11.6.5 Roche Recent Development 11.7 Enlivex Therapeutics 11.7.1 Enlivex Therapeutics Company Details 11.7.2 Enlivex Therapeutics Business Overview 11.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Introduction 11.7.4 Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) 11.7.5 Enlivex Therapeutics Recent Development 11.8 Immune Pharmaceuticals 11.8.1 Immune Pharmaceuticals Company Details 11.8.2 Immune Pharmaceuticals Business Overview 11.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Introduction 11.8.4 Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) 11.8.5 Immune Pharmaceuticals Recent Development 11.9 Tanabe Pharma 11.9.1 Tanabe Pharma Company Details 11.9.2 Tanabe Pharma Business Overview 11.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Introduction 11.9.4 Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) 11.9.5 Tanabe Pharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Targeted biologic therapies Table 3. Key Players of Novel therapies Table 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2016-2021) Table 8. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2022-2027) Table 10. Immune-Mediated Inflammatory Diseases Treatment Market Trends Table 11. Immune-Mediated Inflammatory Diseases Treatment Market Drivers Table 12. Immune-Mediated Inflammatory Diseases Treatment Market Challenges Table 13. Immune-Mediated Inflammatory Diseases Treatment Market Restraints Table 14. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players (2016-2021) Table 16. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2020) Table 17. Ranking of Global Top Immune-Mediated Inflammatory Diseases Treatment Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Immune-Mediated Inflammatory Diseases Treatment Product Solution and Service Table 21. Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million) Table 24. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2016-2021) Table 25. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2016-2021) Table 29. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million) Table 32. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) (US$ Million) Table 34. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) & (US$ Million) Table 61. GlaxoSmithKline Company Details Table 62. GlaxoSmithKline Business Overview Table 63. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product Table 64. GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million) Table 65. GlaxoSmithKline Recent Development Table 66. Eli Lilly Company Details Table 67. Eli Lilly Business Overview Table 68. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product Table 69. Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million) Table 70. Eli Lilly Recent Development Table 71. AstraZeneca Company Details Table 72. AstraZeneca Business Overview Table 73. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product Table 74. AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million) Table 75. AstraZeneca Recent Development Table 76. Bristol-Myers Company Details Table 77. Bristol-Myers Business Overview Table 78. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product Table 79. Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million) Table 80. Bristol-Myers Recent Development Table 81. Sanofi Company Details Table 82. Sanofi Business Overview Table 83. Sanofi Immune-Mediated Inflammatory Diseases Treatment Product Table 84. Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million) Table 85. Sanofi Recent Development Table 86. Roche Company Details Table 87. Roche Business Overview Table 88. Roche Immune-Mediated Inflammatory Diseases Treatment Product Table 89. Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million) Table 90. Roche Recent Development Table 91. Enlivex Therapeutics Company Details Table 92. Enlivex Therapeutics Business Overview Table 93. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product Table 94. Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million) Table 95. Enlivex Therapeutics Recent Development Table 96. Immune Pharmaceuticals Company Details Table 97. Immune Pharmaceuticals Business Overview Table 98. Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million) Table 99. Immune Pharmaceuticals Recent Development Table 100. Tanabe Pharma Company Details Table 101. Tanabe Pharma Business Overview Table 102. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product Table 103. Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million) Table 104. Tanabe Pharma Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Type: 2020 VS 2027 Figure 2. Targeted biologic therapies Features Figure 3. Novel therapies Features Figure 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. Pharmacy Store Case Studies Figure 7. Online Pharmacy Stroe Case Studies Figure 8. Immune-Mediated Inflammatory Diseases Treatment Report Years Considered Figure 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions: 2020 VS 2027 Figure 12. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2022-2027) Figure 13. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players in 2020 Figure 14. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2020 Figure 16. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2016-2021) Figure 17. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2022-2027) Figure 18. North America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2016-2027) Figure 20. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2016-2027) Figure 21. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2016-2027) Figure 22. United States Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2016-2027) Figure 26. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2016-2027) Figure 27. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2016-2027) Figure 28. Germany Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2016-2027) Figure 36. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2016-2027) Figure 37. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2016-2027) Figure 38. China Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2016-2027) Figure 46. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2016-2027) Figure 47. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2016-2027) Figure 48. Mexico Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2016-2027) Figure 52. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2016-2027) Figure 53. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2016-2027) Figure 54. Turkey Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. GlaxoSmithKline Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) Figure 58. Eli Lilly Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) Figure 59. AstraZeneca Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) Figure 60. Bristol-Myers Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) Figure 61. Sanofi Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) Figure 62. Roche Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) Figure 63. Enlivex Therapeutics Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) Figure 64. Immune Pharmaceuticals Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) Figure 65. Tanabe Pharma Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

GlaxoSmithKline Eli Lilly AstraZeneca Bristol-Myers Sanofi Roche Enlivex Therapeutics Immune Pharmaceuticals Tanabe Pharma